NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis

While the recognition of microbial infection often occurs at the cell surface via Toll-like receptors, the cytosol of the cell is also under surveillance for microbial products that breach the cell membrane. An important outcome of cytosolic recognition is the induction of IFNα and IFNβ, which are critical mediators of immunity against both bacteria and viruses. Like many intracellular pathogens, a significant fraction of the transcriptional response to Mycobacterium tuberculosis infection depends on these type I interferons, but the recognition pathways responsible remain elusive. In this work, we demonstrate that intraphagosomal M. tuberculosis stimulates the cytosolic Nod2 pathway that responds to bacterial peptidoglycan, and this event requires membrane damage that is actively inflicted by the bacterium. Unexpectedly, this recognition triggers the expression of type I interferons in a Tbk1- and Irf5-dependent manner. This response is only partially impaired by the loss of Irf3 and therefore, differs fundamentally from those stimulated by bacterial DNA, which depend entirely on this transcription factor. This difference appears to result from the unusual peptidoglycan produced by mycobacteria, which we show is a uniquely potent agonist of the Nod2/Rip2/Irf5 pathway. Thus, the Nod2 system is specialized to recognize bacteria that actively perturb host membranes and is remarkably sensitive to mycobacteria, perhaps reflecting the strong evolutionary pressure exerted by these pathogens on the mammalian immune system.

• Publication year

  2009

• Venue

  PLoS Pathogens

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.ppat.1000500PMID 19578435PMCID 2698121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC

  2009cited by this paper
• Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

  2008cited by this paper
• A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.

  2008cited by this paper
• Role for lysosomal enzyme β-hexosaminidase in the control of mycobacteria infection

  2008cited by this paper
• The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response

  2008cited by this paper
• Distinct TLR- and NLR-Mediated Transcriptional Responses to an Intracellular Pathogen

  2008influential reference
• A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation

  2008cited by this paper
• Type I IFN are host modulators of strain‐specific Listeria monocytogenes virulence

  2008cited by this paper
• Bacterial Ligands Generated in a Phagosome Are Targets of the Cytosolic Innate Immune System

  2007cited by this paper
• Intracellular NOD‐like receptors in innate immunity, infection and disease

  2007cited by this paper
• Type I interferon signaling is required for activation of the inflammasome during Francisella infection

  2007cited by this paper
• The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis

  2007cited by this paper
• Nod-Like Receptors: Cytosolic Watchdogs for Immunity against Pathogens

  2007cited by this paper
• Mycobacterium tuberculosis and the environment within the phagosome

  2007cited by this paper
• Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling.

  2007cited by this paper
• Innate recognition of intracellular bacteria.

  2007cited by this paper
• Interferon Regulatory Factor 7 Is Activated by a Viral Oncoprotein through RIP-Dependent Ubiquitination

  2007cited by this paper
• NOD2 Pathway Activation by MDP or Mycobacterium tuberculosis Infection Involves the Stable Polyubiquitination of Rip2*

  2007influential reference
• Function of a Mycobacterial Major Facilitator Superfamily Pump Requires a Membrane-Associated Lipoprotein

  2007cited by this paper
• The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1

  2007influential reference
• M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells.

  2007cited by this paper
• Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected Macrophages

  2007cited by this paper
• The Hypervirulent Mycobacterium tuberculosis Strain HN878 Induces a Potent TH1 Response followed by Rapid Down-Regulation1

  2007cited by this paper
• ESAT-6 from Mycobacterium tuberculosis Dissociates from Its Putative Chaperone CFP-10 under Acidic Conditions and Exhibits Membrane-Lysing Activity

  2007cited by this paper
• A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system

  2007influential reference
• Breaching the great wall: peptidoglycan and microbial interactions

  2006cited by this paper
• Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor

  2006cited by this paper
• Recognition of cytosolic DNA activates an IRF3-dependent innate immune response.

  2006influential reference
• Pathogen recognition and innate immunity.

  2006influential reference
• Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-αβ Receptor and STAT11

  2005cited by this paper
• Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors

  2005cited by this paper
• Structure and metabolism of peptidoglycan and molecular requirements allowing its detection by the Drosophila innate immune system.

  2005cited by this paper
• Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1.

  2005cited by this paper
• Mutually dependent secretion of proteins required for mycobacterial virulence.

  2005cited by this paper
• The role of peptidoglycan in pathogenesis.

  2005cited by this paper
• NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis

  2005cited by this paper
• TLR Signaling in the Gut in Health and Disease1

  2005cited by this paper
• The RIP kinases: crucial integrators of cellular stress.

  2005cited by this paper
• The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling*

  2005cited by this paper
• The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases.

  2005cited by this paper
• Identification of the namH Gene, Encoding the Hydroxylase Responsible for the N-Glycolylation of the Mycobacterial Peptidoglycan*

  2005cited by this paper
• Immune Activation of Type I IFNs by Listeria monocytogenes Occurs Independently of TLR4, TLR2, and Receptor Interacting Protein 2 but Involves TANK-Binding Kinase 11

  2005cited by this paper
• Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island

  2004cited by this paper
• IFN Regulatory Factor 3-Dependent Induction of Type I IFNs by Intracellular Bacteria Is Mediated by a TLR- and Nod2-Independent Mechanism1

  2004cited by this paper
• Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.

  2004cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT‐6 secretion

  2004cited by this paper
• Exogenous Gamma and Alpha/Beta Interferon Rescues Human Macrophages from Cell Death Induced by Bacillus anthracis

  2004cited by this paper
• Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

  2004cited by this paper
• Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection

  2004cited by this paper
• Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection

  2004cited by this paper
• Inhibition of Response to Alpha Interferon by Mycobacterium tuberculosis

  2003cited by this paper
• An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

  2003cited by this paper
• Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan

  2003cited by this paper
• Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

  2003cited by this paper
• Peptidoglycan Molecular Requirements Allowing Detection by Nod1 and Nod2*

  2003cited by this paper
• Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2

  2003cited by this paper
• Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

  2003cited by this paper
• The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue

  2003cited by this paper
• Genetic requirements for mycobacterial survival during infection

  2003cited by this paper
• Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis1

  2002cited by this paper
• Innate recognition of bacteria by a macrophage cytosolic surveillance pathway

  2002cited by this paper
• Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG

  2002cited by this paper
• Cutting Edge: A Murine, IL-12-Independent Pathway of IFN-γ Induction by Gram-Negative Bacteria Based on STAT4 Activation by Type I IFN and IL-18 Signaling1

  2002cited by this paper
• Production of Type I IFN Sensitizes Macrophages to Cell Death Induced by Listeria monocytogenes1

  2002influential reference
• Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1

  2001cited by this paper
• Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB*

  2001cited by this paper
• Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β

  2001cited by this paper
• Comprehensive identification of conditionally essential genes in mycobacteria

  2001cited by this paper
• Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21

  2000cited by this paper
• RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase.

  1998cited by this paper
• Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.

  1998cited by this paper
• Effects of aerosolized interferon-alpha in patients with pulmonary tuberculosis.

  1998cited by this paper
• Variation in protection by BCG: implications of and for heterologous immunity.

  1995cited by this paper
• The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.

  1995cited by this paper
• Immortalization of macrophages from mouse bone marrow and fetal liver.

  1990cited by this paper
• Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes.

  1988cited by this paper
• Natural and recombinant interferons inhibit epithelial cell invasion by Shigella spp

  1986cited by this paper
• Role of interferon in streptococcal infection in the mouse.

  1986cited by this paper
• Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey.

  1970cited by this paper

• Whole blood transcriptional responses associated with bacterial burden in pulmonary tuberculosis

  2026cites this paper
• Trained immunity in pulmonary infectious diseases: Mechanisms and implications

  2026cites this paper
• Self-aggregating Lactiplantibacillus plantarum enhances type-I interferon responses via the cytosolic sensors NOD2 and cGAS

  2026cites this paper
• Nucleotide‐Binding Oligomerization Domain 2 in Signaling, Immunity, and Mycobacterial Infection

  2025cites this paper
• The dual role of type I interferons in bacterial infections: from immune defense to pathogenesis

  2025cites this paper
• Cellular and Molecular Mechanisms of Innate Memory Responses.

  2025cites this paper
• An essential role for TASL in mouse autoimmune pathogenesis and Toll-like receptor signaling

  2025cites this paper
• Interferons in health and disease.

  2025cites this paper
• Comprehensive review and reflective evaluation of cell therapies for tuberculosis

  2025cites this paper
• Mycobacterial ESAT-6 triggers cGAS-STING pathway via the GSDMD-NT dependent mitochondria dysfunction

  2025cites this paper
• For Better or Worse: Type I Interferon Responses in Bacterial Infection

  2025cites this paper
• Advancing roles of nitric oxide in tuberculosis: Promising targets for novel anti-TB therapeutics.

  2025cites this paper
• Functional characterization of RIP2 in large yellow croaker (Larimichthys crocea), a protein involved in the host antiviral responses via NF-κΒ, IRF3/7 related signaling.

  2024cites this paper
• Phagosome-mediated activation of STING during diverse bacterial infections

  2024cites this paper
• Mutual regulations between Toxoplasma gondii and type I interferon

  2024cites this paper
• 4-Anilinoquinazoline Derivatives as the First Potent NOD1-RIPK2 Signaling Pathway Inhibitors at the Nanomolar Range.

  2024cites this paper
• Differential Host Gene Expression in Response to Infection by Different Mycobacterium tuberculosis Strains—A Pilot Study

  2024cites this paper
• Proteome overview of exosome derived from plasma of cows infected with Mycobacterium bovis.

  2024cites this paper
• The multiple roles of interferon regulatory factor family in health and disease

  2024cites this paper
• Macrophage polarization or repolarization in tuberculosis

  2024cites this paper
• Multifaceted roles and regulation of nucleotide-binding oligomerization domain containing proteins

  2023cites this paper
• Microbial cues stimulate linear growth in undernourished mice

  2023cites this paper
• [NOD2 signaling is at the interface between microbiota and linear growth in malnourished mice].

  2023cites this paper
• A nod to the bond between NOD2 and mycobacteria

  2023influential citation
• Characteristics of the interferon regulatory factor IRF5 and its stimulation expression by Elizabethkingia miricola Infection in black-spotted frog (Pelophylax nigromaculatus)

  2023cites this paper
• Microbe-mediated intestinal NOD2 stimulation improves linear growth of undernourished infant mice

  2023cites this paper
• Pathogenicity of Type I Interferons in Mycobacterium tuberculosis

  2023cites this paper
• Transcriptomic Analysis of Mycobacterial Infected Macrophages Reveals a High MOI Specific Type I IFN Signaling

  2023cites this paper
• Peptidoglycan-induced modulation of metabolic and inflammatory responses

  2023cites this paper
• Mycobacterium tuberculosis and its clever approaches to escape the deadly macrophage

  2023cites this paper
• Phase variation as a major mechanism of adaptation in Mycobacterium tuberculosis complex

  2023cites this paper
• Peptide-pulsed dendritic cells' immunomodulating effect regarding Mycobacterium tuberculosis growth in macrophages.

  2023cites this paper
• RIPK2: A New Therapeutic Target for Inflammatory Diseases

  2023cites this paper
• Modern Clinical Mycobacterium tuberculosis Strains Leverage Type I IFN Pathway for a Proinflammatory Response in the Host

  2022cites this paper
• Non-invasive administration of AAV to target lung parenchymal cells and develop SARS-CoV-2-susceptible mice

  2022cites this paper
• Phase variation as a major mechanism of adaptation in Mycobacterium tuberculosis complex

  2022cites this paper
• N-phosphonacetyl-L-aspartate enhances type I interferon anti-viral responses through activation of non-canonical NOD2 signaling

  2022cites this paper
• Host–Pathogen Interactions of Marine Gram-Positive Bacteria

  2022cites this paper
• Identification of Inflammation-Related Genes and Exploration of Regulatory Mechanisms in Patients with Osteonecrosis of the Femoral Head

  2022cites this paper
• Analysis of miRNA Expression Profiling of RIP2 Knockdown in Chicken HD11 Cells When Infected with Avian Pathogenic E. coli (APEC)

  2022cites this paper
• Mice Dually Disrupted for Nod2 and Mincle Manifest Early Bacteriological Control but Late Susceptibility During Mycobacterium tuberculosis Infection

  2022cites this paper
• Mycobacterium avium subsp. paratuberculosis and microbiome profile of patients in a referral gastrointestinal diseases centre in the Sudan

  2022cites this paper
• Identi�cation of in�ammation-related genes and exploration of regulatory mechanisms in patients with osteonecrosis of the femoral head

  2022cites this paper
• Interferon regulatory factor 5 in Rheumatoid arthritis and systemic lupus erythematosus

  2021cites this paper
• Association between NOD2 gene polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran

  2021cites this paper
• Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation

  2021cites this paper
• Type I Interferons Are Involved in the Intracellular Growth Control of Mycobacterium abscessus by Mediating NOD2-Induced Production of Nitric Oxide in Macrophages

  2021cites this paper
• Advances on the Role and Applications of Interleukin-1 in Tuberculosis

  2021cites this paper
• Impact of Type I Interferons on Susceptibility to Bacterial Pathogens.

  2021cites this paper
• Identi cation of differentially expressed genes and hub genes of human hosts with tuberculosis through an integrated bioinformatics strategy

  2021cites this paper
• Interferons at the crossroad of cell death pathways during gastrointestinal inflammation and infection.

  2021cites this paper
• Type I interferon decreases macrophage energy metabolism during mycobacterial infection.

  2021cites this paper
• Pegylated-interferon-alpha treatment modulating the immune response of cytotoxic lymphocytes in cervical intraepithelial neoplasia

  2021cites this paper
• Role of NLRs in the Regulation of Type I Interferon Signaling, Host Defense and Tolerance to Inflammation

  2021cites this paper
• The Innate Immune Response to Mycobacterium tuberculosis Infection.

  2021cites this paper
• Perspectives and Advances in the Understanding of Tuberculosis.

  2021cites this paper
• Immunotherapeutic Role of NOD-2 and TLR-4 Signaling as an Adjunct to Antituberculosis Chemotherapy.

  2021cites this paper
• Interferons: Tug of War Between Bacteria and Their Host

  2021cites this paper
• NOD1 and NOD2 Activation by Diverse Stimuli: a Possible Role for Sensing Pathogen-Induced Endoplasmic Reticulum Stress

  2020cites this paper
• Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins

  2020cites this paper
• PYK2 controls intestinal inflammation via activation of IRF5 in macrophages

  2020cites this paper
• RIPK2 NODs to XIAP and IBD.

  2020cites this paper
• Immune Reconstitution Disorders: Spotlight on Interferons

  2020cites this paper
• The diverse roles of RIP kinases in host-pathogen interactions

  2020cites this paper
• NOD1 and NOD2 in inflammatory and infectious diseases

  2020cites this paper
• Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis

  2020cites this paper
• Impact and prognosis of the expression of IFN-α among tuberculosis patients

  2020cites this paper
• Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.

  2019cites this paper
• Modern clinical Mtb strains leverage the type I IFN pathway for a pro-inflammatory response in the host

  2019cites this paper
• Immunology of Mycobacterium tuberculosis Infections

  2019cites this paper
• Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen

  2019cites this paper
• Microbial recognition by GEF-H1 controls IKKε mediated activation of IRF5

  2019cites this paper
• The Synergistic Role of Diet and Exercise in the Prevention, Pathogenesis, and Management of Ulcerative Colitis: An Underlying Metabolic Mechanism

  2019cites this paper
• Association between Genetic Polymorphisms of Inflammatory Response Genes and Acute Pancreatitis

  2019cites this paper
• Reducing IRF5 expression attenuates colitis in mice, but impairs the clearance of intestinal pathogens

  2019cites this paper
• NOD1 and NOD2 in inflammation, immunity and disease.

  2019cites this paper
• RIPK2 polymorphisms and susceptibility to tuberculosis in a Western Chinese Han population.

  2019cites this paper
• Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria

  2019influential citation
• Regulating IRFs in IFN Driven Disease

  2019cites this paper
• Type I interferons in tuberculosis: Foe and occasionally friend

  2018influential citation
• Cyclic di-AMP-mediated interaction between Mycobacterium tuberculosis &Dgr;cnpB and macrophages implicates a novel strategy for improving BCG vaccination

  2018cites this paper
• IRF5 Is Required for Bacterial Clearance in Human M1-Polarized Macrophages, and IRF5 Immune-Mediated Disease Risk Variants Modulate This Outcome

  2018cites this paper
• Success stories of natural product-based hybrid molecules for multi-factorial diseases.

  2018cites this paper
• NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases

  2018cites this paper
• Structural basis of RIP2 activation and signaling

  2018cites this paper
• TNF‐α‐Induced NOD2 and RIP2 Contribute to the Up‐Regulation of Cytokines Induced by MDP in Monocytic THP‐1 Cells

  2018cites this paper
• Frontline Science: RIP2 promotes house dust mite–induced allergic airway inflammation

  2018cites this paper
• Advances and challenges in targeting IRF5, a key regulator of inflammation

  2018cites this paper
• Understanding the Host Immune Response Against Mycobacterium tuberculosis Infection

  2018cites this paper
• Granulomatous Response to Mycobacterium tuberculosis Infection

  2018cites this paper
• Nucleotide-binding oligomerization domain 1 is dispensable for host immune responses against pulmonary infection of Acinetobacter baumannii in mice

  2018cites this paper
• The impact of macrophage iron export during mycobacterium tuberculosis infection

  2018cites this paper
• Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis

  2018cites this paper
• IRF5-mediated immune responses and its implications in immunological disorders

  2018cites this paper
• Type 1 Interferon in the Human Intestine-A Co-ordinator of the Immune Response to the Microbiota.

  2017cites this paper
• IFN-β: A Contentious Player in Host–Pathogen Interaction in Tuberculosis

  2017cites this paper
• Killing Mycobacterium tuberculosis In Vitro: What Model Systems Can Teach Us

  2017cites this paper
• MiR‐20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3

  2017cites this paper
• From bacterial killing to immune modulation: Recent insights into the functions of lysozyme

  2017cites this paper
• Molecular basis of mycobacterial survival in macrophages

  2017cites this paper